წყაროები
ძირითადი სტატიები
McDonald LC, Gerding DN, Johnson S, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018 Mar 19;66(7):e1-e48.სრული ტექსტი აბსტრაქტი
Johnson S, Lavergne V, Skinner AM, et al. Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults. Clin Infect Dis. 2021 Jun 24:ciab549.სრული ტექსტი აბსტრაქტი
van Prehn J, Reigadas E, Vogelzang EH, et al. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clin Microbiol Infect. 2021 Dec;27 Suppl 2:S1-S21.სრული ტექსტი აბსტრაქტი
Beinortas T, Burr NE, Wilcox MH, et al. Comparative efficacy of treatments for Clostridium difficile infection: a systematic review and network meta-analysis. Lancet Infect Dis. 2018 Sep;18(9):1035-44. აბსტრაქტი
Nelson RL, Suda KJ, Evans CT. Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults. Cochrane Database Syst Rev. 2017;(3):CD004610.სრული ტექსტი აბსტრაქტი
გამოყენებული სტატიები
1. Lawson PA, Citron DM, Tyrrell KL, et al. Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O'Toole 1935) Prévot 1938. Anaerobe. 2016 Aug;40:95-9. აბსტრაქტი
2. McDonald LC, Gerding DN, Johnson S, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018 Mar 19;66(7):e1-e48.სრული ტექსტი აბსტრაქტი
3. Poutanen SM, Simor AE. Clostridium difficile-associated diarrhea in adults. CMAJ. 2004 Jul 6;171(1):51-8.სრული ტექსტი აბსტრაქტი
4. Balsells E, Shi T, Leese C, et al. Global burden of Clostridium difficile infections: a systematic review and meta-analysis. J Glob Health. 2019 Jun;9(1):010407.სრული ტექსტი აბსტრაქტი
5. Turner NA, Grambow SC, Woods CW, et al. Epidemiologic trends in Clostridioides difficile infections in a regional community hospital network. JAMA Netw Open. 2019 Oct 2;2(10):e1914149.სრული ტექსტი აბსტრაქტი
6. Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015 Feb 26;372(9):825-34.სრული ტექსტი აბსტრაქტი
7. Finn E, Andersson FL, Madin-Warburton M. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI. BMC Infect Dis. 2021 May 19;21(1):456.სრული ტექსტი აბსტრაქტი
8. Abrahamian FM, Talan DA, Krishnadasan A, et al; EMERGEncy ID NET Study Group. Clostridium difficile infection among US emergency department patients with diarrhea and no vomiting. Ann Emerg Med. 2017 Jul;70(1):19-27;e4. აბსტრაქტი
9. Bartlett JG, Perl TM. The new Clostridium difficile - what does it mean? N Engl J Med. 2005 Dec 8;353(23):2503-5. აბსტრაქტი
10. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005 Dec 8;353(23):2442-9.სრული ტექსტი აბსტრაქტი
11. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005 Dec 8;353(23):2433-41.სრული ტექსტი აბსტრაქტი
12. Bartlett JG. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med. 2006 Nov 21;145(10):758-64. აბსტრაქტი
13. Carlson TJ, Blasingame D, Gonzales-Luna AJ, et al. Clostridioides difficile ribotype 106: a systematic review of the antimicrobial susceptibility, genetics, and clinical outcomes of this common worldwide strain. Anaerobe. 2020 Apr;62:102142. აბსტრაქტი
14. Sheitoyan-Pesant C, Abou Chakra CN, Pépin J, et al. Clinical and healthcare burden of multiple recurrences of Clostridium difficile infection. Clin Infect Dis. 2016 Mar 1;62(5):574-80.სრული ტექსტი აბსტრაქტი
15. Ma GK, Brensinger CM, Wu Q, et al. Increasing incidence of multiply recurrent Clostridium difficile infection in the United States: a cohort study. Ann Intern Med. 2017 Aug 1;167(3):152-8. აბსტრაქტი
16. van Rossen TM, Ooijevaar RE, Vandenbroucke-Grauls CMJE, et al. Prognostic factors for severe and recurrent Clostridioides difficile infection: a systematic review. Clin Microbiol Infect. 2022 Mar;28(3):321-31.სრული ტექსტი აბსტრაქტი
17. Mehta P, Nahass RG, Brunetti L. Acid suppression medications during hospitalization as a risk factor for recurrence of clostridioides difficile Infection: systematic review and meta-analysis. Clin Infect Dis. 2021 Jul 1;73(1):e62-8.სრული ტექსტი აბსტრაქტი
18. UK Health Security Agency. C. difficile infection: monthly data by prior trust exposure. Jun 2023 [internet publication].სრული ტექსტი
19. European Centre for Disease Prevention and Control. Healthcare-associated infections: Clostridium difficile infections - annual epidemiological report for 2016-2017. Nov 2022 [internet publication].სრული ტექსტი
20. Borren NZ, Ghadermarzi S, Hutfless S, et al. The emergence of Clostridium difficile infection in Asia: a systematic review and meta-analysis of incidence and impact. PLoS One. 2017 May 2;12(5):e0176797.სრული ტექსტი აბსტრაქტი
21. Treatment of Clostridium difficile infection. Med Lett Drugs Ther. 2011 Feb 21;53(1358):14-5. აბსტრაქტი
22. Schroeder MS. Clostridium difficile-associated diarrhea. Am Fam Physician. 2005 Mar 1;71(5):921-8.სრული ტექსტი აბსტრაქტი
23. Anjewierden S, Han Z, Brown AM, et al. Risk factors for Clostridioides difficile colonization among hospitalized adults: a meta-analysis and systematic review. Infect Control Hosp Epidemiol. 2021 May;42(5):565-72. აბსტრაქტი
24. Miller AC, Segre AM, Pemmaraju SV, et al. Association of household exposure to primary Clostridioides difficile infection with secondary infection in family members. JAMA Netw Open. 2020 Jun 1;3(6):e208925.სრული ტექსტი აბსტრაქტი
25. Slimings C, Riley TV. Antibiotics and healthcare facility-associated Clostridioides difficile infection: systematic review and meta-analysis 2020 update. J Antimicrob Chemother. 2021 Jun 18;76(7):1676-88.სრული ტექსტი აბსტრაქტი
26. Teng C, Reveles KR, Obodozie-Ofoegbu OO, et al Clostridium difficile infection risk with important antibiotic classes: an analysis of the FDA Adverse Event Reporting System. Int J Med Sci. 2019 May 7;16(5):630-5.სრული ტექსტი აბსტრაქტი
27. Tariq R, Cho J, Kapoor S, et al. Low risk of primary Clostridium difficile infection with tetracyclines: a systematic review and metaanalysis. Clin Infect Dis. 2018 Feb 1;66(4):514-22. აბსტრაქტი
28. Dingle KE, Didelot X, Quan TP, et al. Effects of control interventions on Clostridium difficile infection in England: an observational study. Lancet Infect Dis. 2017 Apr;17(4):411-21.სრული ტექსტი აბსტრაქტი
29. Baur D, Gladstone BP, Burkert F, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis. 2017 Sep;17(9):990-1001. აბსტრაქტი
30. Blumenthal KG, Lu N, Zhang Y, et al. Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study. BMJ. 2018 Jun 27;361:k2400.სრული ტექსტი აბსტრაქტი
31. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005 Dec 8;353(23):2442-9.სრული ტექსტი აბსტრაქტი
32. Blixt T, Gradel KO, Homann C, et al. Asymptomatic carriers contribute to nosocomial Clostridium difficile infection: a cohort study of 4508 patients. Gastroenterology. 2017 Apr;152(5):1031-41;e2. აბსტრაქტი
33. Miller AC, Segre AM, Pemmaraju SV, et al. Association of household exposure to primary Clostridioides difficile infection with secondary infection in family members. JAMA Netw Open. 2020 Jun 1;3(6):e208925.სრული ტექსტი აბსტრაქტი
34. Cunningham R, Dale B, Undy B, et al. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect. 2003 Jul;54(3):243-5. აბსტრაქტი
35. US Food and Drug Administration. FDA drug safety communication: Clostridium difficile associated diarrhea can be associated with stomach acid drugs known as proton pump inhibitors (PPIs). Feb 2012 [internet publication].სრული ტექსტი
36. Arriola V, Tischendorf J, Musuuza J, et al. Assessing the risk of hospital-acquired clostridium difficile infection with proton pump inhibitor use: a meta-analysis. Infect Control Hosp Epidemiol. 2016 Dec;37(12):1408-17.სრული ტექსტი აბსტრაქტი
37. Oshima T, Wu L, Li M, et al. Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis. J Gastroenterol. 2018 Jan;53(1):84-94. აბსტრაქტი
38. Cao F, Chen CX, Wang M, et al. Updated meta-analysis of controlled observational studies: proton-pump inhibitors and risk of Clostridium difficile infection. J Hosp Infect. 2018 Jan;98(1):4-13. აბსტრაქტი
39. Azab M, Doo L, Doo DH, et al. Comparison of the hospital-acquired Clostridium difficile infection risk of using proton pump inhibitors versus histamine-2 receptor antagonists for prophylaxis and treatment of stress ulcers: a systematic review and meta-analysis. Gut Liver. 2017 Nov 15;11(6):781-8.სრული ტექსტი აბსტრაქტი
40. Nguyen GC, Kaplan GG, Harris ML, et al. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008 Jun;103(6):1443-50. აბსტრაქტი
41. Razik R, Rumman A, Bahreini Z, et al. Recurrence of Clostridium difficile infection in ptients with inflammatory bowel disease: the RECIDIVISM study. Am J Gastroenterol. 2016 Aug;111(8):1141-6. აბსტრაქტი
42. Tariq R, Law CCY, Khanna S, et al. The impact of Clostridium difficile infection on mortality in patients with inflammatory bowel disease: a systematic review and meta-analysis. J Clin Gastroenterol. 2019 Feb;53(2):127-33. აბსტრაქტი
43. Balram B, Battat R, Al-Khoury A, et al. Risk factors associated with Clostridium difficile infection in inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis. 2019 Jan 1;13(1):27-38.სრული ტექსტი აბსტრაქტი
44. Donnelly JP, Wang HE, Locke JE, et al. Hospital-onset Clostridium difficile infection among solid organ transplant recipients. Am J Transplant. 2015 Nov;15(11):2970-7.სრული ტექსტი აბსტრაქტი
45. Paudel S, Zacharioudakis IM, Zervou FN, et al. Prevalence of Clostridium difficile infection among solid organ transplant recipients: a meta-analysis of published studies. PLoS One. 2015 Apr 17;10(4):e0124483.სრული ტექსტი აბსტრაქტი
46. Zacharioudakis IM, Ziakas PD, Mylonakis E. Clostridium difficile infection in the hematopoietic unit: a meta-analysis of published studies. Biol Blood Marrow Transplant. 2014 Oct;20(10):1650-4.სრული ტექსტი აბსტრაქტი
47. Luo Y, Zhang S, Shang H, et al. Prevalence of Clostridium difficile infection in the hematopoietic transplantation setting: update of systematic review and meta-analysis. Front Cell Infect Microbiol. 2022;12:801475.სრული ტექსტი აბსტრაქტი
48. Phatharacharukul P, Thongprayoon C, Cheungpasitporn W, et al. The risks of incident and recurrent Clostridium difficile-associated diarrhea in chronic kidney disease and end-stage kidney disease patients: a systematic review and meta-analysis. Dig Dis Sci. 2015 Oct;60(10):2913-22. აბსტრაქტი
49. Sanchez TH, Brooks JT, Sullivan PS, et al; Adult/Adolescent Spectrum of HIV Disease Study Group. Bacterial diarrhea in persons with HIV infection, United States, 1992-2002. Clin Infect Dis. 2005 Dec 1;41(11):1621-7.სრული ტექსტი აბსტრაქტი
50. Anand A, Glatt AE. Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis. 1993 Jul;17(1):109-13. აბსტრაქტი
51. Li Y, Cai H, Sussman DA, et al. Association between immunosuppressive therapy and outcome of Clostridioides difficile infection: systematic review and meta-analysis. Dig Dis Sci. 2022 Aug;67(8):3890-903. აბსტრაქტი
52. Southern WN, Rahmani R, Aroniadis O, et al. Postoperative Clostridium difficile-associated diarrhea. Surgery. 2010 Jul;148(1):24-30.სრული ტექსტი აბსტრაქტი
53. Khorasani S, Dossa F, McKechnie T, et al. Association between preoperative oral antibiotics and the incidence of postoperative Clostridium difficile infection in adults undergoing elective colorectal resection: a systematic review and meta-analysis. Dis Colon Rectum. 2020 Apr;63(4):545-61. აბსტრაქტი
54. Harries RL, Ansell J, Codd RJ, et al. A systematic review of Clostridium difficile infection following reversal of ileostomy. Colorectal Dis. 2017 Oct;19(10):881-7. აბსტრაქტი
55. Furuya-Kanamori L, Wangdi K, Yakob L, et al. 25-hydroxyvitamin D concentrations and Clostridium difficile infection: a meta-analysis. JPEN J Parenter Enteral Nutr. 2017 Jul;41(5):890-5. აბსტრაქტი
56. Su GL, Ko CW, Bercik P, et al. AGA clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders. Gastroenterology. 2020 Aug;159(2):697-705. აბსტრაქტი
57. Kelly CR, Fischer M, Allegretti JR, et al. ACG clinical guidelines: prevention, diagnosis, and treatment of Clostridioides difficile infections. Am J Gastroenterol. 2021 Jun 1;116(6):1124-47. აბსტრაქტი
58. McFarland LV, Kullar R, Johnson S, et al. Why do ACG and AGA guidelines differ for the use of probiotics and the prevention of CDI? Am J Gastroenterol. 2022 Mar 1;117(3):501. აბსტრაქტი
59. Goldenberg JZ, Yap C, Lytvyn L, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2017 Dec 19;12:CD006095.სრული ტექსტი აბსტრაქტი
60. Shen NT, Maw A, Tmanova LL, et al. Timely use of probiotics in hospitalized adults prevents Clostridium difficile infection: a systematic review with meta-regression analysis. Gastroenterology. 2017 Jun;152(8):1889-900;e9.სრული ტექსტი აბსტრაქტი
61. Ma Y, Yang JY, Peng X, et al. Which probiotic has the best effect on preventing Clostridium difficile-associated diarrhea? A systematic review and network meta-analysis. J Dig Dis. 2020 Feb;21(2):69-80. აბსტრაქტი
62. Deschênes P, Chano F, Dionne LL, et al. Efficacy of the World Health Organization-recommended handwashing technique and a modified washing technique to remove Clostridium difficile from hands. Am J Infect Control. 2017 Aug 1;45(8):844-8. აბსტრაქტი
63. Banach DB, Bearman G, Barnden M, et al. Duration of contact precautions for acute-care settings. Infect Control Hosp Epidemiol. 2018 Feb;39(2):127-44.სრული ტექსტი აბსტრაქტი
64. Rutala WA, Weber DJ. Sterilization, high-level disinfection, and environmental cleaning. Infect Dis Clin North Am. 2011 Mar;25(1):45-76. აბსტრაქტი
65. National Institute for Health and Care Excellence. Infection prevention and control. Apr 2014 [internet publication].სრული ტექსტი
66. Kato H, Hagihara M, Asai N, et al. A systematic review and meta-analysis of decontamination methods to prevent hospital environmental contamination and transmission of Clostridioidesdifficile. Anaerobe. 2022 Feb;73:102478. აბსტრაქტი
67. Lewis SR, Schofield-Robinson OJ, Rhodes S, et al. Chlorhexidine bathing of the critically ill for the prevention of hospital-acquired infection. Cochrane Database Syst Rev. 2019 Aug 30;8(8):CD012248.სრული ტექსტი აბსტრაქტი
68. Alshrari AS, Hudu SA, Elmigdadi F, et al. The urgent threat of Clostridioides difficile infection: a glimpse of the drugs of the future, with related patents and prospects. Biomedicines. 2023 Feb 1;11(2):426.სრული ტექსტი აბსტრაქტი
69. Tschudin-Sutter S, Kuijper EJ, Durovic A, et al. Guidance document for prevention of Clostridium difficile infection in acute healthcare settings. Clin Microbiol Infect. 2018 Oct;24(10):1051-4.სრული ტექსტი აბსტრაქტი
70. Arimoto J, Horita N, Kato S, et al. Diagnostic test accuracy of glutamate dehydrogenase for Clostridium difficile: systematic review and meta-analysis. Sci Rep. 2016 Jul 15;6:29754.სრული ტექსტი აბსტრაქტი
71. Deshpande A, Pasupuleti V, Pant C, et al. Potential value of repeat stool testing for Clostridium difficile stool toxin using enzyme immunoassay? Curr Med Res Opin. 2010 Nov;26(11):2635-41.სრული ტექსტი აბსტრაქტი
72. Johnson S, Lavergne V, Skinner AM, et al. Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults. Clin Infect Dis. 2021 Jun 24:ciab549.სრული ტექსტი აბსტრაქტი
73. Zhang VRY, Woo ASJ, Scaduto C, et al. Systematic review on the definition and predictors of severe Clostridiodes difficile infection. J Gastroenterol Hepatol. 2021 Jan;36(1):89-104.სრული ტექსტი აბსტრაქტი
74. Bishop EJ, Tiruvoipati R. Management of Clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA/SHEA, ESCMID and ASID guidelines. J Antimicrob Chemother. 2022 Dec 23;78(1):21-30.სრული ტექსტი აბსტრაქტი
75. National Institute for Health and Care Excellence. Clostridioides difficile infection: antimicrobial prescribing NICE guideline [NG199]. 23 Jul 2021 [internet publication].სრული ტექსტი
76. van Prehn J, Reigadas E, Vogelzang EH, et al. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clin Microbiol Infect. 2021 Dec;27 Suppl 2:S1-S21.სრული ტექსტი აბსტრაქტი
77. Beinortas T, Burr NE, Wilcox MH, et al. Comparative efficacy of treatments for Clostridium difficile infection: a systematic review and network meta-analysis. Lancet Infect Dis. 2018 Sep;18(9):1035-44. აბსტრაქტი
78. Okumura H, Fukushima A, Taieb V, et al. Fidaxomicin compared with vancomycin and metronidazole for the treatment of Clostridioides (Clostridium) difficile infection: a network meta-analysis. J Infect Chemother. 2020 Jan;26(1):43-50.სრული ტექსტი აბსტრაქტი
79. Tashiro S, Mihara T, Sasaki M, et al. Oral fidaxomicin versus vancomycin for the treatment of Clostridioides difficile infection: a systematic review and meta-analysis of randomized controlled trials. J Infect Chemother. 2022 Nov;28(11):1536-45. აბსტრაქტი
80. Liao JX, Appaneal HJ, Vicent ML, et al. Path of least recurrence: a systematic review and meta-analysis of fidaxomicin versus vancomycin for Clostridioides difficile infection. Pharmacotherapy. 2022 Nov;42(11):810-27. აბსტრაქტი
81. Nelson RL, Suda KJ, Evans CT. Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults. Cochrane Database Syst Rev. 2017;(3):CD004610.სრული ტექსტი აბსტრაქტი
82. Khanna S, Shin A, Kelly CP. Management of Clostridium difficile infection in inflammatory bowel disease: expert review from the Clinical Practice Updates Committee of the AGA Institute. Clin Gastroenterol Hepatol. 2017 Feb;15(2):166-74.სრული ტექსტი აბსტრაქტი
83. D'Aoust J, Battat R, Bessissow T. Management of inflammatory bowel disease with Clostridium difficile infection. World J Gastroenterol. 2017 Jul 21;23(27):4986-5003.სრული ტექსტი აბსტრაქტი
84. Cimolai N. Does oral vancomycin use necessitate therapeutic drug monitoring? Infection. 2020 Apr;48(2):173-82. აბსტრაქტი
85. Sholeh M, Krutova M, Forouzesh M, et al. Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2020 Sep 25;9(1):158.სრული ტექსტი აბსტრაქტი
86. Ng QX, Loke W, Foo NX, et al. A systematic review of the use of rifaximin for Clostridium difficile infections. Anaerobe. 2019 Feb;55:35-9. აბსტრაქტი
87. Kechagias KS, Chorepsima S, Triarides NA, et al. Tigecycline for the treatment of patients with Clostridium difficile infection: an update of the clinical evidence. Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1053-8. აბსტრაქტი
88. Jaber MR, Olafsson S, Fung WL, et al. Clinical review of the management of fulminant Clostridium difficile infection. Am J Gastroenterol. 2008 Dec;103(12):3195-203;quiz 3204. აბსტრაქტი
89. Forrester JD, Colling KP, Diaz JJ, et al. Surgical Infection Society guidelines for total abdominal colectomy versus diverting loop ileostomy with antegrade intra-colonic lavage for the surgical management of severe or fulminant, non-perforated Clostridioides difficile Colitis. Surg Infect (Larchmt). 2022 Mar;23(2):97-104. აბსტრაქტი
90. Felsenreich DM, Gachabayov M, Rojas A, et al. Meta-analysis of postoperative mortality and morbidity after total abdominal colectomy versus loop ileostomy with colonic lavage for fulminant Clostridium difficile colitis. Dis Colon Rectum. 2020 Sep;63(9):1317-26. აბსტრაქტი
91. McKechnie T, Lee Y, Springer JE, et al. Diverting loop ileostomy with colonic lavage as an alternative to colectomy for fulminant Clostridioides difficile: a systematic review and meta-analysis. Int J Colorectal Dis. 2020 Jan;35(1):1-8. აბსტრაქტი
92. Singh T, Bedi P, Bumrah K, et al. Fecal microbiota transplantation and medical therapy for Clostridium difficile infection : meta-analysis of randomized controlled trials. J Clin Gastroenterol. 2022 Nov-Dec 01;56(10):881-8. აბსტრაქტი
93. Louie TJ, Miller MA, Mullane KM, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011 Feb 3;364(5):422-31.სრული ტექსტი აბსტრაქტი
94. Stevens VW, Nelson RE, Schwab-Daugherty EM, et al. Comparative effectiveness of vancomycin and metronidazole for the prevention of recurrence and death in patients with Clostridium difficile infection. JAMA Intern Med. 2017 Apr 1;177(4):546-53. აბსტრაქტი
95. Sehgal K, Zandvakili I, Tariq R, et al. Systematic review and meta-analysis: efficacy of vancomycin taper and pulse regimens in Clostridioides difficile infection. Expert Rev Anti Infect Ther. 2022 Apr;20(4):577-83. აბსტრაქტი
96. Wilcox MH, Gerding DN, Poxton IR, et al. Bezlotoxumab for prevention of recurrent Clostridium difficile infection. N Engl J Med. 2017 Jan 26;376(4):305-17.სრული ტექსტი აბსტრაქტი
97. Alhifany AA, Almutairi AR, Almangour TA, et al. Comparing the efficacy and safety of faecal microbiota transplantation with bezlotoxumab in reducing the risk of recurrent Clostridium difficile infections: a systematic review and Bayesian network meta-analysis of randomised controlled trials. BMJ Open. 2019 Nov 7;9(11):e031145.სრული ტექსტი აბსტრაქტი
98. National Institute for Health and Care Excellence. Faecal microbiota transplant for recurrent Clostridioides difficile infection. Aug 2022 [internet publication].სრული ტექსტი
99. Minkoff NZ, Aslam S, Medina M, et al. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile). Cochrane Database Syst Rev. 2023 Apr 25;4(4):CD013871.სრული ტექსტი აბსტრაქტი
100. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013 Jan 31;368(5):407-15.სრული ტექსტი აბსტრაქტი
101. Lee CH, Steiner T, Petrof EO, et al. Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: a randomized clinical trial. JAMA. 2016 Jan 12;315(2):142-9.სრული ტექსტი აბსტრაქტი
102. Hota SS, Sales V, Tomlinson G, et al. Oral vancomycin followed by fecal transplantation versus tapering oral vancomycin treatment for recurrent Clostridium difficile infection: an open-label, randomized controlled trial. Clin Infect Dis. 2017 Feb 1;64(3):265-71.სრული ტექსტი აბსტრაქტი
103. Lai CY, Sung J, Cheng F, et al. Systematic review with meta-analysis: review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation. Aliment Pharmacol Ther. 2019 Feb;49(4):354-63. აბსტრაქტი
104. Du C, Luo Y, Walsh S, et al. Oral fecal microbiota transplant capsules are safe and effective for recurrent Clostridioides difficile infection: a systematic review and meta-analysis. J Clin Gastroenterol. 2021 Apr 1;55(4):300-8. აბსტრაქტი
105. Kelly CR, Yen EF, Grinspan AM, et al. Fecal microbiota transplantation Is highly effective in real-world practice: initial results from the FMT National Registry. Gastroenterology. 2021 Jan; 160(1):183-92.e3.სრული ტექსტი აბსტრაქტი
106. Tariq R, Pardi DS, Bartlett MG, et al. Low cure rates in controlled trials of fecal microbiota transplantation for recurrent Clostridium difficile infection: a systematic review and meta-analysis. Clin Infect Dis. 2019 Apr 8;68(8):1351-8.სრული ტექსტი აბსტრაქტი
107. Rokkas T, Gisbert JP, Gasbarrini A, et al. A network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent Clostridium difficile infection. United European Gastroenterol J. 2019 Oct;7(8):1051-63.სრული ტექსტი აბსტრაქტი
108. Hui W, Li T, Liu W, et al. Fecal microbiota transplantation for treatment of recurrent C. difficile infection: an updated randomized controlled trial meta-analysis. PLoS One. 2019 Jan 23;14(1):e0210016.სრული ტექსტი აბსტრაქტი
109. Baunwall SMD, Andreasen SE, Hansen MM, et al. Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol Hepatol. 2022 Sep 21:S2468-1253(22)00276-X. აბსტრაქტი
110. Moayyedi P, Yuan Y, Baharith H, et al. Faecal microbiota transplantation for Clostridium difficile-associated diarrhoea: a systematic review of randomised controlled trials. Med J Aust. 2017 Aug 21;207(4):166-72.სრული ტექსტი აბსტრაქტი
111. Hvas CL, Dahl Jørgensen SM, Jørgensen SP, et al. Fecal microbiota transplantation is superior to fidaxomicin for treatment of recurrent Clostridium difficile infection. Gastroenterology. 2019 Apr;156(5):1324-32.e3.სრული ტექსტი აბსტრაქტი
112. Beran A, Sharma S, Ghazaleh S, et al. Predictors of fecal microbiota transplant failure in Clostridioides difficile infection : an updated meta-analysis. J Clin Gastroenterol. 2023 Apr 1;57(4):389-99. აბსტრაქტი
113. Ramai D, Zakhia K, Fields PJ, et al. Fecal microbiota transplantation (FMT) with colonoscopy is superior to enema and nasogastric tube while comparable to capsule for the treatment of recurrent Clostridioides difficile infection: a systematic review and meta-analysis. Dig Dis Sci. 2021 Feb;66(2):369-80. აბსტრაქტი
114. Tang G, Yin W, Liu W. Is frozen fecal microbiota transplantation as effective as fresh fecal microbiota transplantation in patients with recurrent or refractory Clostridium difficile infection: a meta-analysis? Diagn Microbiol Infect Dis. 2017 Aug;88(4):322-9. აბსტრაქტი
115. Furuya-Kanamori L, Doi SA, Paterson DL, et al. Upper versus lower gastrointestinal delivery for transplantation of fecal microbiota in recurrent or refractory Clostridium difficile infection: a collaborative analysis of individual patient data from 14 studies. J Clin Gastroenterol. 2017 Feb;51(2):145-50. აბსტრაქტი
116. Gangwani MK, Aziz M, Aziz A, et al. Fresh versus frozen versus lyophilized fecal microbiota transplant for recurrent Clostridium difficile infection: a systematic review and network meta-analysis. J Clin Gastroenterol. 2023 Mar 1;57(3):239-45. აბსტრაქტი
117. Wang S, Xu M, Wang W, et al. Systematic review: adverse events of fecal microbiota transplantation. PLoS One. 2016 Aug 16;11(8):e0161174.სრული ტექსტი აბსტრაქტი
118. Marcella C, Cui B, Kelly CR, et al. Systematic review: the global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020. Aliment Pharmacol Ther. 2021 Jan;53(1):33-42. აბსტრაქტი
119. Pomares Bascuñana RÁ, Veses V, Sheth CC. Effectiveness of fecal microbiota transplant for the treatment of Clostridioides difficile diarrhea: a systematic review and meta-analysis. Lett Appl Microbiol. 2021 Aug;73(2):149-58.სრული ტექსტი აბსტრაქტი
120. Khoruts A, Rank KM, Newman KM, et al. Inflammatory bowel disease affects the outcome of fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol. 2016 Oct; 14(10):1433-8.სრული ტექსტი აბსტრაქტი
121. Chen T, Zhou Q, Zhang D, et al. Effect of faecal microbiota transplantation for treatment of Clostridium difficile infection in patients with inflammatory bowel disease: a systematic review and meta-analysis of cohort studies. J Crohns Colitis. 2018 May 25;12(6):710-7.სრული ტექსტი აბსტრაქტი
122. Tariq R, Syed T, Yadav D, et al. Outcomes of fecal microbiota transplantation for C. difficile infection in inflammatory bowel disease : a systematic review and meta-analysis. J Clin Gastroenterol. 2023 Mar 1;57(3):285-93. აბსტრაქტი
123. Shogbesan O, Poudel DR, Victor S, et al. A systematic review of the efficacy and safety of fecal microbiota transplant for Clostridium difficile infection in immunocompromised patients. Can J Gastroenterol Hepatol. 2018 Sep 2;2018:1394379.სრული ტექსტი აბსტრაქტი
124. US Food and Drug Administration. Important safety alert regarding use of fecal microbiota for transplantation and risk of serious adverse reactions due to transmission of multi-drug resistant organisms. Jun 2019 [internet publication].სრული ტექსტი
125. US Food and Drug Administration. Fecal microbiota for transplantation: safety alert - risk of serious adverse events likely due to transmission of pathogenic organisms. Apr 2020 [internet publication].სრული ტექსტი
126. US Food and Drug Administration. Safety alert regarding use of fecal microbiota for transplantation and additional safety protections pertaining to monkeypox virus. Aug 2022 [internet publication].სრული ტექსტი
127. Ianiro G, Murri R, Sciumè GD, et al. Incidence of bloodstream infections, length of hospital stay, and survival in patients with recurrent Clostridioides difficile infection treated with fecal microbiota transplantation or antibiotics: a prospective cohort study. Ann Intern Med. 2019 Nov 19;171(10):695-702. აბსტრაქტი
128. Bafeta A, Yavchitz A, Riveros C, et al. Methods and reporting studies assessing fecal microbiota transplantation: a systematic review. Ann Intern Med. 2017 Jul 4;167(1):34-9. აბსტრაქტი
129. Feuerstadt P, Louie TJ, Lashner B, et al. SER-109, an oral microbiome therapy for recurrent Clostridioides difficile infection. N Engl J Med. 2022 Jan 20;386(3):220-9.სრული ტექსტი აბსტრაქტი
130. Louie T, Golan Y, Khanna S, et al. VE303, a defined bacterial consortium, for prevention of recurrent Clostridioides difficile infection: a randomized clinical trial. JAMA. 2023 Apr 25;329(16):1356-66. აბსტრაქტი
131. ClinicalTrials.gov. Exploratory study to assess delivery of LMN-201 components via enteric capsules in the gut of individuals with ostomies. ClinicalTrials.gov identifier: NCT04893239. Mar 2022 [internet publication].სრული ტექსტი
132. ClinicalTrials.gov. LMN-201 for prevention of C. difficile infection recurrence. ClinicalTrials.gov identifier: NCT05330182. Nov 2022 [internet publication].სრული ტექსტი
133. Vickers RJ, Tillotson GS, Nathan R, et al. Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study. Lancet Infect Dis. 2017 Jul;17(7):735-44.სრული ტექსტი აბსტრაქტი
134. Kokai-Kun JF, Roberts T, Coughlin O, et al. Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial. Lancet Infect Dis. 2019 May;19(5):487-96. აბსტრაქტი
135. McCoy RM, Klick A, Hill S, et al. Luminal toxin-binding agents for Clostridium difficile infection. J Pharm Pract. 2016 Aug;29(4):361-7. აბსტრაქტი
136. Saha S, Sehgal K, Singh S, et al. Postinfection irritable bowel syndrome following Clostridioides difficile infection: a systematic-review and meta-analysis. J Clin Gastroenterol. 2022 Feb 1;56(2):e84-93. აბსტრაქტი
137. Almroth S, Mohale M, Latham MC. Grandma ahead of her time: traditional ways of diarrhoea management in Lesotho. J Diarrhoeal Dis Res. 1997 Sep;15(3):167-72. აბსტრაქტი
138. Brown CC, Manis MM, Bohm NM, et al. Oral vancomycin for secondary prophylaxis of Clostridium difficile infection. Ann Pharmacother. 2019 Apr;53(4):396-401. აბსტრაქტი
ამ მასალის გამოყენება ექვემდებარება ჩვენს განცხადებას